#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Liver transplant rejection Acute lymphocytic leukaemia Waldenstrom's macroglobulinaemia recurrent CDKL5 deficiency disorder Crohn's disease Hereditary angioedema Acute promyelocytic leukaemia Cutaneous lupus erythematosus Drug eruption Chondrosarcoma metastatic Still's disease Acute graft versus host disease in intestine Anti-myelin-associated glycoprotein antibodies positive Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Diagnostics Retinitis pigmentosa – Life with Disease Mucopolysaccharidosis I – Treatment Nodal marginal zone B-cell lymphoma – Life with Disease Prader-Willi syndrome – Life with Disease Ocular melanoma – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Retinitis pigmentosa Loeys-Dietz syndrome Rhabdomyosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vancomycin Nefopam Hydrochloride Olodaterol CITRIC ACID ANHYDROUS VHB937 Morf-057 Topotecan HYDROGEN PEROXIDE Riboflavin Sodium Phosphate Belimumab Cenegermin Pf-06835375 Teriflunomide Fluocinolone Acetonide Bictegravir Azd3470 Vinorelbine Tartrate Xanomeline Tartrate Telmisartan HUMAN FIBROBLASTS More therapies…

    Learn about Your Condition

    Synovial sarcoma metastatic Skin cancer Dyspnoea Facial paresis Weaning failure Herpes simplex Gestational diabetes Malignant lymphoid neoplasm Vaginal infection Hypertriglyceridaemia Normal pressure hydrocephalus Medullary thyroid cancer Haemodynamic instability Periarthritis Hypoaesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Deucrictibant
    • Icatibant
    Bulgaria France Germany Hungary Ireland Italy +4

  • Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease recurrent
    • Hodgkin’s disease refractory
    Investigated Drugs:
    • Brentuximab Vedotin
    • Pembrolizumab
    • Ruxolitinib
    Italy

  • Study on Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Lenalidomide
    Italy

  • Study of Modified Anti-Platelet Therapy with Prasugrel, Ticagrelor, and Clopidogrel in Heart Attack Patients Undergoing Complete Revascularization

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Clopidogrel
    • Prasugrel
    • Ticagrelor
    Italy The Netherlands Spain

  • Study on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir
    • Lamivudine
    Italy

  • Study on the Effectiveness and Safety of Silibinin for Patients with Active Cushing’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Silibinin
    Italy

  • Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

    Not recruiting

    4 1 1
    Austria Bulgaria Germany Italy The Netherlands Poland +2

  • Study Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Vincristine
    • Bendamustine
    • Bendamustine Hydrochloride
    Italy

  • Title: Study of Solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety

    Not recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Solrikitug
    Belgium Italy The Netherlands Poland Spain

  • Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol
    Belgium Bulgaria Denmark France Germany Greece +6
Previous Page
1 … 24 25 26 27 28 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!